Nov 05,2020

Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health

AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all operating assets and the proprietary portfolio of Cohero Health, Inc. (“Cohero Health”), a digital therapeutics company transforming respiratory disease management for asthma and chronic obstructive pulmonary disorder (COPD). Financial details of the acquisition were not disclosed. Over the years, Cohero Health has developed BreatheSmart Connect digital health platform to enable care coordination, BreatheSmart connected app, HeroTracker Sensors for inhalers, and a range of spirometers.

COLLABORATION MERGERS & ACQUISITION

#product & service

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 09,2020

Respiratory platform NuvoAir shows high acceptance of its home spirometry

Studies on paediatric pulmonology from the UK and Sweden have demonstrated that both young and adult patients with respiratory disease can achieve good quality spirometry at home, without clinical supervision, when using the NuvoAir Home platform. The platform allows patients to self-monitor their respiratory health and share clinically relevant data with their care teams, who can view these data remotely via a healthcare portal. Other key findings show that patient adherence to self-monitoring schedules is high and that the technology is well accepted by patients and parents.

CLINICAL STUDY

#coaching

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 22,2019

Propeller Health: 84% of People with Asthma May Be Using Their Inhaler Incorrectly

The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two “puffs” of their inhaler to receive the prescribed dose.

CLINICAL STUDY

#connected device

View Analyst & Ambassador Comments
Go to original news
Apr 18,2019

Swedish respiratory health startup NuvoAir raises $3M

This week Swedish startup NuvoAir, best known for making respiratory monitors, scored $3 million in new funding. The latest round was led by Inustrifonden, with participation from Investment AB Spiltan. The company made a name for itself with a smartphone spirometer able to conduct lung function assessments in a home environment. Last year the company launched the Air Next system, a small and portable device that connects to users’ smartphones or tablets using Bluetooth LE. The tool was designed for people living with respiratory conditions such as asthma, COPD and cystic fibrosis.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
May 20,2019

3 New Insights About COPD From Propeller’s Digital Health Tools

This week at ATS 2019, Propeller Health presented three new findings on COPD, all of which used digital health tools to monitor patients’ medication use in a real-world setting and reveal new insights about their disease. This is the latest research to demonstrate how digital health tools continue to revolutionize the way we treat respiratory disease. When providers and patients can monitor the patient’s daily medication use, they’re more likely to adhere to their maintenance medication regimen and thereby experience fewer symptoms and require emergency treatment less often.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
May 21,2019

Anthem Blue Cross and Blue Shield Collaborates with Propeller Health to Support Consumers with COPD

Anthem Blue Cross and Blue Shield in Ohio (Anthem) today announced the rollout of an innovative new program, with Propeller Health’s collaboration, to help improve health outcomes for Ohio consumers enrolled in Anthem’s Medicare Advantage health plans who have chronic obstructive pulmonary disease (COPD).

COLLABORATION PARTNERSHIP

#insurance

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 24,2018

Propeller publishes paper showing improvements in asthma symptoms and control

Propeller Health studied the impact of Propeller on a group of 95 participants from Louisville during the pilot phase of our work with the city. Research found that people showed consistent and sustained improvements in asthma outcomes over the 13-month study period, including more than 39% fewer rescue inhaler uses, 23% more symptom-free days, and improved asthma control.

CLINICAL STUDY

#mobile app

#connected device

View Analyst & Ambassador Comments
Go to original news
Mar 20,2018

Research overview: Findings shared at the 2018 American Academy of Allergy, Asthma, and Immunology Conference

Earlier this month, Propeller Health attended the American Academy of Allergy, Asthma and Immunology (AAAAI) and World Allergy Organization Joint Conference in Orlando, FL. The conference highlights key advancements in research through symposiums and poster sessions. Propeller, in collaboration with the Children’s Hospital Colorado, presented inhaler sensor data that assessed patterns of rescue and controller medication use among children and adults with self-reported persistent asthma. Using sensor data from almost 1,400 patients, the company observed rates of controller inhaler adherence by age, time of day, and season. Propeller Health found that adolescents and young adults had lower rates of adherence compared to older adults who demonstrated improved adherence with increasing age.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Apr 02,2018

Results From a Large Public Health Study on Asthma; Successfully Reduces the Burden of Asthma in Louisville

Today Propeller Health and peer-reviewed healthcare journal, Health Affairs, published results from a cross-sector partnership in Louisville, KY, that successfully reduced the burden of asthma. The program deployed inhaler sensors and a digital health platform to monitor where and when local residents used their inhaled medications for asthma, assessed the environmental conditions that might have influenced asthma symptoms, and shared those findings with participants and city decision-makers. The authors found that participants experienced several positive clinical outcomes, including a 78% reduction in rescue inhaler use and a 48% improvement in symptom-free days.

PRODUCT

#connected device

View Analyst & Ambassador Comments
Go to original news
Jun 27,2018

How Digital Health Interventions are Changing the One-Size-Fits-All Approach to Asthma Treatment

The symptoms of asthma may vary dramatically from patient to patient. Age of onset, triggers and mechanism of disease are factors that also influence the symptoms of asthma, the way the disease is expressed and its severity. Propeller Health recently partnered with research scientists from Children’s Hospital Colorado to better understand two of the most challenging complexities of asthma: medication adherence and the assessment of asthma control.

CLINICAL STUDY

#connected device

View Analyst & Ambassador Comments
Go to original news
Subscribe to RESPIRATORY